Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 9.94B | 10.28B | 10.94B | 9.67B | 8.54B | 5.66B |
Gross Profit | 2.17B | 2.36B | 2.60B | 2.38B | 2.68B | 1.29B |
EBITDA | 247.00M | 456.00M | 2.61B | 2.30B | 2.72B | 2.71B |
Net Income | -1.62B | -1.52B | 1.96B | 1.89B | 1.89B | 1.99B |
Balance Sheet | ||||||
Total Assets | 23.71B | 22.86B | 26.60B | 26.27B | 11.97B | 10.91B |
Cash, Cash Equivalents and Short-Term Investments | 1.17B | 962.00M | 1.80B | 1.51B | 546.00M | 1.49B |
Total Debt | 547.00M | 12.95B | 14.10B | 15.13B | 4.20B | 3.97B |
Total Liabilities | 18.01B | 17.25B | 19.05B | 20.17B | 7.44B | 7.01B |
Stockholders Equity | 5.28B | 5.17B | 7.09B | 5.64B | 4.19B | 3.53B |
Cash Flow | ||||||
Free Cash Flow | 388.00M | 531.00M | 1.33B | 1.28B | 1.29B | 979.00M |
Operating Cash Flow | 581.00M | 966.00M | 1.90B | 1.82B | 1.76B | 1.34B |
Investing Cash Flow | -414.00M | -470.00M | -134.00M | -11.14B | -1.12B | 592.00M |
Financing Cash Flow | -636.00M | -1.31B | -1.46B | 10.29B | -1.04B | -1.47B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
70 Outperform | $772.78M | 14.68 | 10.28% | 8.59% | -7.24% | -7.30% | |
61 Neutral | $10.08B | 5.96 | 0.94% | 3.00% | 3.04% | -41.02% | |
54 Neutral | $15.39B | 75.91 | -5.59% | 12.22% | -2.82% | -186.41% | |
50 Neutral | $1.64B | ― | -10.43% | 9.86% | -1.56% | -259.58% | |
45 Neutral | $4.51B | 6.84 | -25.69% | 1.89% | -5.83% | -183.85% | |
42 Neutral | $1.28B | ― | -8638.28% | ― | -3.33% | 44.37% | |
40 Underperform | $545.32M | ― | -14.11% | 11.36% | 0.20% | -292.54% |
On August 11, 2025, Celanese Corporation and its subsidiary Celanese US Holdings LLC entered into a new Revolving Credit Agreement, establishing a five-year $1.75 billion unsecured revolving credit facility. This facility replaces a previous agreement from March 2022 and includes a sublimit for letters of credit, with interest rates tied to various benchmarks and the company’s debt ratings. The agreement imposes covenants on leverage and fixed charge coverage ratios, and limits on dividends, mergers, and asset sales. Additionally, Celanese US amended its Term Loan Credit Agreement to include a minimum consolidated fixed charge coverage ratio and other modifications.
The most recent analyst rating on (CE) stock is a Hold with a $66.00 price target. To see the full list of analyst forecasts on Celanese stock, see the CE Stock Forecast page.
On August 12, 2025, Celanese Corporation’s CEO, Scott A. Richardson, will present the company’s second quarter 2025 financial results to investors and analysts via a webcast. The presentation will include non-US GAAP financial measures, which are reconciled with US GAAP measures in accompanying documents available on the company’s website.
The most recent analyst rating on (CE) stock is a Hold with a $66.00 price target. To see the full list of analyst forecasts on Celanese stock, see the CE Stock Forecast page.
During the 2025 Annual Meeting, Celanese shareholders voted on several key proposals including the election of thirteen directors, ratification of KPMG LLP as the independent auditor, and approval of executive compensation. Additionally, shareholders approved amendments to the company’s Charter and By-laws, allowing for changes by majority vote, filling of open Board seats at special meetings, and removal of directors by majority vote. These decisions reflect a significant alignment with shareholder interests and could influence the company’s governance structure and operational flexibility.
The most recent analyst rating on (CE) stock is a Hold with a $66.00 price target. To see the full list of analyst forecasts on Celanese stock, see the CE Stock Forecast page.